Literature DB >> 8586680

DNA amplification and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex.

V A Steingrube1, B A Brown, J L Gibson, R W Wilson, J Brown, Z Blacklock, K Jost, S Locke, R F Ulrich, R J Wallace.   

Abstract

Nineteen reference and 156 clinical strains of the genus Nocardia belonging to 12 taxonomic groups were studied for restriction fragment length polymorphism (RFLP) by using an amplified 439-bp segment of the 65-kDa heat shock protein gene. Of 30 restriction endonucleases, digestion with MspI and then digestion with BsaHI produced RFLP band patterns which separated all 12 groups except N. asteroides type IV from 6 of 12 N. transvalensis isolates and N. carnea from the N. asteroides type VI isolates. Commonly encountered species such as N. nova, N. farcinica, N. brasiliensis sensu stricto, and N. otitidiscaviarum were easily separated. Each taxon resulted in a single RFLP band pattern that included > or = 96% of all biochemically grouped isolates for 9 of 12 taxa with MspI and for 8 of 12 taxa with BsaHI. With the use of both patterns, only 6 of 175 (3.4%) isolates failed to fit the biochemically defined group patterns. These studies provide the first evidence for the separate identities of four antibiogram-defined (but currently unnamed) groups within the N. asteroides complex (types I, II, IV, and VI) and the presence of two subgroups within N. transvalensis. They also provide genotypic evidence for the separate identities of N. nova and N. farcinica. The lack of BstEII recognition sites in amplicons obtained from nocardiae provides a simple and rapid method for the differentiation of nocardiae from mycobacteria. DNA amplification with RFLP analysis is the first rapid method that distinguishes all clinically significant taxa and recognized species within the genus Nocardia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586680      PMCID: PMC228651          DOI: 10.1128/jcm.33.12.3096-3101.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid.

Authors:  V A Steingrube; R J Wallace; B A Brown; Y Pang; B Zeluff; L C Steele; Y Zhang
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Identification of mycobacteria by high-performance liquid chromatography.

Authors:  W R Butler; K C Jost; J O Kilburn
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

3.  Disseminated Nocardia transvalensis infection: an unusual opportunistic pathogen in severely immunocompromised patients.

Authors:  M M McNeil; J M Brown; C H Magruder; K T Shearlock; R A Saul; D P Allred; L Ajello
Journal:  J Infect Dis       Date:  1992-01       Impact factor: 5.226

4.  Antimicrobial susceptibility patterns of Nocardia asteroides.

Authors:  R J Wallace; L C Steele; G Sumter; J M Smith
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

5.  Susceptibility testing of Nocardia species for the clinical laboratory.

Authors:  R J Wallace; L C Steele
Journal:  Diagn Microbiol Infect Dis       Date:  1988-03       Impact factor: 2.803

6.  High-performance liquid chromatography patterns of mycolic acids as criteria for identification of Mycobacterium chelonae, Mycobacterium fortuitum, and Mycobacterium smegmatis.

Authors:  W R Butler; J O Kilburn
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

7.  Identification of mycobacteria by PCR-based sequence determination of the 32-kilodalton protein gene.

Authors:  H Soini; E C Böttger; M K Viljanen
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

8.  Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica.

Authors:  R J Wallace; M Tsukamura; B A Brown; J Brown; V A Steingrube; Y S Zhang; D R Nash
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

9.  Clinical and laboratory features of Nocardia nova.

Authors:  R J Wallace; B A Brown; M Tsukamura; J M Brown; G O Onyi
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

10.  Identification of nocardiae and streptomycetes of medical importance.

Authors:  S K Mishra; R E Gordon; D A Barnett
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

View more
  30 in total

1.  Recognition of a Nocardia transvalensis complex by resistance to aminoglycosides, including amikacin, and PCR-restriction fragment length polymorphism analysis.

Authors:  R W Wilson; V A Steingrube; B A Brown; Z Blacklock; K C Jost; A McNabb; W D Colby; J R Biehle; J L Gibson; R J Wallace
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Use of PCR-restriction enzyme pattern analysis and sequencing database for hsp65 gene-based identification of Nocardia species.

Authors:  Verónica Rodríguez-Nava; Andrée Couble; Gregory Devulder; Jean-Pierre Flandrois; Patrick Boiron; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

3.  Typing of Nocardia farcinica by pulsed-field gel electrophoresis reveals an endemic strain as source of hospital infections.

Authors:  J Blümel; E Blümel; A F Yassin; H Schmidt-Rotte; K P Schaal
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

Review 4.  DNA fingerprinting techniques for microorganisms. A proposal for classification and nomenclature.

Authors:  M Vaneechoutte
Journal:  Mol Biotechnol       Date:  1996-10       Impact factor: 2.695

5.  Organisms designated as Nocardia asteroides drug pattern type VI are members of the species Nocardia cyriacigeorgica.

Authors:  Patricia S Conville; Frank G Witebsky
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

6.  Identification of pathogenic Nocardia species by reverse line blot hybridization targeting the 16S rRNA and 16S-23S rRNA gene spacer regions.

Authors:  Meng Xiao; Fanrong Kong; Tania C Sorrell; Yongyan Cao; Ok Cha Lee; Ying Liu; Vitali Sintchenko; Sharon C A Chen
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

7.  Rapid identification of Nocardia farcinica clinical isolates by a PCR assay targeting a 314-base-pair species-specific DNA fragment.

Authors:  June M Brown; Kim N Pham; Michael M McNeil; Brent A Lasker
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

8.  Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria.

Authors:  B A Brown; R J Wallace; G Onyi
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

Review 9.  Pulmonary and psoas muscle nocardiosis in a patient with lupus nephritis: a case report and review of the literature.

Authors:  Ji Yun Noh; Hee Jin Cheong; Jung Yeon Heo; Won Suk Choi; Yu Mi Jo; Joon Young Song; Chang Kyu Lee; Sung Il Kim; Woo Joo Kim
Journal:  Rheumatol Int       Date:  2009-11-03       Impact factor: 2.631

10.  Assignment of reference 5'-end 16S rDNA sequences and species-specific sequence polymorphisms improves species identification of Nocardia.

Authors:  Fanrong Kong; Sharon C A Chen; Xiaoyou Chen; Vitali Sintchenko; Catriona Halliday; Lin Cai; Zhongsheng Tong; Ok Cha Lee; Tania C Sorrell
Journal:  Open Microbiol J       Date:  2009-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.